Discover

OCS
Oculis Holding AG
12.68
3 x 12.57
1 x 12.74
bid
ask
-
0.08
0.63%
12:34 PM
timesize
Ytd-36.50%
1y-29.44%
12.57
day range
12.79
10.52
52 week range
34.48
Open12.74Prev Close12.76Low12.57High12.79Mkt Cap724.91M
Vol67.49KAvg Vol684.87KEPS-2.13P/E-5.95Forward P/E-6.94
Beta0.51Short Ratio1.06Inst. Own37.91%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg12.37200-d Avg21.731yr Est51.82

OCS News

benzinga.com
Oculis Acquires Accure's Privosegtor And ACT-02 Assets In Deal Worth $3.8M Upfront Cash And Up To 2,

Transaction will enhance Oculis’ strategic flexibility and ownership of Privosegtor while driving lo

Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis' Position as an Emerging Leading Neuro-Ophthalmology Company
globenewswire.com
Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fort

ZUG, Switzerland and BARCELONA, Spain, August 10, 2026 Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (

benzinga.com
Oculis Holding Q2 EPS $(0.20) Beats $(0.48) Estimate, Sales $392.150K Beat $260.000K Estimate

Oculis Holding (NASDAQ:OCS) reported quarterly losses of $(0.20) per share which beat the analyst co

Oculis Holding AG (OCS) Reports Q2 Loss, Tops Revenue Estimates
zacks.com
Oculis Holding AG (OCS) Reports Q2 Loss, Tops Revenue Estimates

Oculis Holding AG (OCS) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus

Oculis Reports Q2 2026 Financial Results and Provides Company Update
globenewswire.com
Oculis Reports Q2 2026 Financial Results and Provides Company Update

ZUG, Switzerland, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (Ocu

benzinga.com
HC Wainwright & Co. Maintains Buy on Oculis Holding, Maintains $26 Price Target

HC Wainwright & Co. analyst Yi Chen maintains Oculis Holding (NASDAQ:OCS) with a Buy and main

benzinga.com
Oculis To Submit IND For Privosegtor In Acute MS Relapses In Q4 2026, Backed By Positive FDA Pre-IND

The FDA Division of Neurology provided positive feedback supporting a regulatory pathway for Privose

Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses
globenewswire.com
Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treat

The FDA Division of Neurology provided positive feedback supporting a regulatory pathway for Privose

Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses
globenewswire.com
Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treat

ZUG, Switzerland, Aug. 03, 2026 (GLOBE NEWSWIRE) -- The FDA Division of Neurology provided positive

OCS Group to buy Mitie for $4.17 billion
reuters.com
OCS Group to buy Mitie for $4.17 billion

British outsourcer Mitie ‌has agreed to be acquired by rival OCS Group ​International for a ​total v

Intuitive Surgical, Netflix And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
benzinga.com
Intuitive Surgical, Netflix And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

U.S. stock futures lower, Nasdaq 100 down 2%. Intuitive Surgical shares dip 11.3% after Q2 earnings

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
globenewswire.com
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

ZUG, Switzerland, July 08, 2026 (GLOBE NEWSWIRE) -- The attached notification relates to the vesting

Oculis to Participate at the Piper Sandler Virtual Ophthalmology Conference
globenewswire.com
Oculis to Participate at the Piper Sandler Virtual Ophthalmology Conference

ZUG, Switzerland, July 2, 2026 – Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Compan

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS
prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG -

NEW YORK, June 25, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS
globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG -

NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS
prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG -

NEW YORK, June 18, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

OCS Investors Have Opportunity to Join Oculis Holding AG Fraud Investigation with the Schall Law Firm
globenewswire.com
OCS Investors Have Opportunity to Join Oculis Holding AG Fraud Investigation with the Schall Law Fir

LOS ANGELES, June 17, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights li

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS
globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG -

NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

OCS Investors Have Opportunity to Join Oculis Holding AG Fraud Investigation with the Schall Law Firm
prnewswire.com
OCS Investors Have Opportunity to Join Oculis Holding AG Fraud Investigation with the Schall Law Fir

LOS ANGELES, June 11, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litiga

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS
prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG -

NEW YORK, June 11, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026
globenewswire.com
Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026

ZUG, Switzerland, June 11, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Ocu

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
globenewswire.com
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

ZUG, Switzerland, June 10, 2026 (GLOBE NEWSWIRE) -- The attached notifications relate to the vesting

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
globenewswire.com
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

ZUG, Switzerland, June 09, 2026 (GLOBE NEWSWIRE) -- The attached notification relates to the purchas

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS
globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG -

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

Dell Technologies To Gain Nearly 79%? Here Are 10 Analyst Calls Investors Should Know
benzinga.com
Dell Technologies To Gain Nearly 79%? Here Are 10 Analyst Calls Investors Should Know

Wall Street analysts updated views on notable stocks. See changes on analyst ratings page. Price tar

12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

Why Taylor Morrison Home Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Taylor Morrison Home Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

Taylor Morrison Home soared 23.28% to $72.12 in pre-market trading after Berkshire Hathaway announce

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

Microchip Technology, Alumis, Terrestrial Energy, Bright Minds Biosciences And Other Big Stocks Moving Higher On Tuesday
benzinga.com
Microchip Technology, Alumis, Terrestrial Energy, Bright Minds Biosciences And Other Big Stocks Movi

This AeroVironment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
benzinga.com
This AeroVironment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Zoom To Rally Around 38%? Here Are 10 Top Analyst Forecasts For Tuesday
benzinga.com
Zoom To Rally Around 38%? Here Are 10 Top Analyst Forecasts For Tuesday

Earnings Scheduled For November 6, 2025
benzinga.com
Earnings Scheduled For November 6, 2025

TD Synnex, Walgreens, Savers Value Village And Other Big Stocks Moving Higher On Friday
benzinga.com
TD Synnex, Walgreens, Savers Value Village And Other Big Stocks Moving Higher On Friday

benzinga.com
Intel, Noah Holdings, Twilio And Other Big Stocks Moving Higher On Wednesday

U.S. stocks traded lower, with the Dow Jones dropping over 250 points on Wednesday. Here are some bi

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  On Monday, 89 stocks made new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 469 companies hit new 52-week lows.